首页> 中文期刊> 《中国社区医师》 >氨溴索不同给药途径治疗小儿支气管肺炎临床疗效比较

氨溴索不同给药途径治疗小儿支气管肺炎临床疗效比较

             

摘要

Objective:To compare and analyze the clinical effects of using different ambroxol administration route in the treatment of children with pediatric bronchial pneumonia.Methods:64 children with pediatric bronchial pneumonia were selected.According to the random number table method,they were randomly divided into the observation group and the control group.The observation group were treated with ambroxol atomizing inhalation on the basis of conventional treatment.The control group were treated with ambroxol injection on the basis of conventional treatment.The clinical treatment effects and adverse reactions of children in two groups were compared and observed.Results:The treatment total effective rate(93.8%) of the observation group was significantly higher than (78.1%) of the control group.The adverse reaction incidence rate(0%) of the observation group was significantly lower than (9.4% ) of the control group.The differences were statistically significant(P<0.05).Conclusion:Using atomizing inhalation method when the application of ambroxol treatment in children with pediatric bronchial pneumonia can effectively improve the clinical treatment effect.It has less adverse reaction.The children more easily accept.It can be used as the ideal mode of clinical treatment of pediatric bronchial pneumonia.%目的:比较分析小儿支气管肺炎患儿采用不同氨溴索给药途径治疗的临床效果。方法:收治小儿支气管肺炎患儿64例,按照随机数字表法分为观察组和对照组,观察组在常规治疗基础上给予氨溴索雾化吸入治疗,对照组在常规治疗基础上给予氨溴索注射治疗,对比观察两组患儿临床治疗效果以及不良反应情况。结果:观察组治疗总有效率(93.8%)明显高于对照组(78.1%);观察组不良反应发生率(0)明显低于对照组(9.4%),差异具有统计学意义(P<0.05)。结论:小儿支气管肺炎患儿应用氨溴索治疗时采用雾化吸入方式,可有效提高临床治疗效果,且不良反应较轻,患儿更容易接受,可作为临床治疗小儿支气管肺炎的理想方式。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号